ANIPANI PHARMACEUTICALS INCvs its industry peers
A metric-by-metric comparison of ANI PHARMACEUTICALS INC against Pharmaceutical Preparations — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ANIP본 종목 | — | 15.8x#4 | — | — | 43.8%#5 | 510.5%#2 | 12.6%#3 | 13.1%#2 | 16.9%#2 | — | -23.1%#13 | — |
| KARD | $1.8B#1 | — | 3.0x#2 | — | — | — | — | 0.0%#3 | — | — | — | — |
| SNDX | $1.8B#2 | — | 118.5x#13 | 10.4x#4 | 627.8%#2 | 10.5%#7 | -158.4%#7 | -1890.2%#15 | -1205.8%#6 | — | 24.4%#10 | — |
| SEPN | $1.8B#3 | — | 4.6x#8 | 38.7x#6 | 4174.5%#1 | 31.9%#6 | -148.6%#6 | -12.6%#8 | — | — | 171.1%#4 | — |
| DMRA | $1.7B#4 | 3.7x#2 | 3.4x#4 | — | — | -878.8%#13 | — | -40.7%#12 | — | — | 829.3%#1 | — |
| ETON | $1.7B#5 | — | 37.5x#12 | 21.9x#5 | 104.9%#4 | -20.4%#8 | -1.1%#5 | -9.9%#7 | -1.8%#4 | 4#2 | 255.9%#3 | — |
| FBRX | $1.6B#6 | — | 8.9x#11 | 45406.7x#7 | -99.8%#8 | -95.5%#10 | -196269.4%#8 | -37.7%#11 | -45.2%#5 | — | 598.7%#2 | — |
| ANAB | $1.6B#7 | — | 127.8x#14 | 6.9x#3 | 157.0%#3 | 90.9%#4 | 20.4%#2 | -103.8%#14 | — | — | 148.3%#6 | — |
| AVLN | $1.6B#8 | — | 3.9x#5 | — | — | — | — | 0.0%#3 | — | — | — | — |
| BCAX | $1.5B#9 | — | 3.3x#3 | — | — | -102.9%#11 | — | -29.4%#9 | — | — | 95.8%#8 | — |
| XERS | $1.5B#10 | — | — | 5.3x#2 | 43.7%#6 | 101.0%#3 | 8.5%#4 | — | 20.6%#1 | — | 7.5%#11 | — |
| LBRX | $1.5B#11 | 2.1x#1 | 4.6x#9 | — | — | 60.1%#5 | — | -7.6%#6 | — | — | 156.3%#5 | — |
| TYRA | $1.5B#12 | — | 4.3x#7 | — | — | -38.7%#9 | — | -33.9%#10 | — | — | 107.2%#7 | — |
| INVA | $1.5B#13 | 4.9x#3 | 1.2x#1 | 3.7x#1 | 14.7%#7 | 1059.2%#1 | 39.8%#1 | 22.0%#1 | 14.7%#3 | 5#1 | 0.8%#12 | — |
| AVBP | $1.5B#14 | — | 4.0x#6 | — | — | -106.6%#12 | — | -45.3%#13 | — | — | 55.8%#9 | — |
| TRAX | $1.5B#15 | — | 8.7x#10 | — | — | — | — | 0.0%#3 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice